Wednesday, March 11, 2026

 

Many patients want to talk about their faith. Neurologists often don't know how.



A new paper offers practical strategies for incorporating spiritual assessment into routine neurological care




University of California - Los Angeles Health Sciences





People living with neurological diseases such as Parkinson's disease, dementia and epilepsy face not only physical decline, but also profound questions about identity, purpose, and meaning. Yet physicians best positioned to address those concerns do not have the adequate training and tools to do so, a new paper states.

The paper, published in the journal Neurology Clinical Practice by researchers from UCLA Health, the University of Colorado, Harvard Medical School and Brown University, argues that spiritual assessment should become a routine part of neurological care, and offers practical guidance for how clinicians can make it happen.

The paper describes why neurologists are uniquely suited to engage patients on matters of spirituality, and why the field's reluctance to do so may be leaving an important dimension of patient care unaddressed.

“Neurologic diseases attack the very things that define who we are: our memory, our movement, our ability to communicate,” said lead author Dr. Indu Subramanian, a movement disorders neurologist at the David Geffen School of Medicine at UCLA and the VA Greater Los Angeles Healthcare System. “In that context, a patient's spirituality isn't peripheral to their medical care. It's often central to how they cope, find meaning and make decisions about treatment.”

Research cited in the paper suggests that roughly 60% of American adults express interest in having their religious or spiritual concerns acknowledged in a medical setting. At the same time, studies consistently show that clinicians, including neurologists, are reluctant to raise the subject, citing discomfort, lack of training and time constraints.

Subramanian and the paper coauthors argue this gap can have real consequences to patients. Unaddressed spiritual distress has been associated with poorer quality of life in patients with serious illness, while spiritual support has been linked to improved coping, stronger patient-clinician relationships and better alignment around treatment goals. For patients with progressive neurological conditions, who often experience an erosion of identity and memory alongside physical decline, these factors can be especially significant.

The paper draws on a biopsychosocial-spiritual model of care, an expansion of the widely adopted biopsychosocial framework, which recognizes spirituality as a distinct and measurable dimension of health, alongside physical, psychological and social factors. This model has been endorsed by multiple major medical organizations and is increasingly recognized as relevant to neurological care.

Simple Tools for a Sensitive Conversation

A key contribution of the paper is its practical guidance for neurologists who want to integrate spiritual assessment into their practice without extensive additional training or time.

The authors recommend beginning with a brief, two-question screen that takes less than two minutes: asking whether spirituality or faith is important to a patient in thinking about their health, and whether they have or would like someone to speak with about those concerns. For clinicians who prefer a less direct approach, the paper suggests open-ended questions such as "What do I need to know about you as a person to give you the best care possible?" or “From where do you draw your strength?”

The authors also describe a Faith, Importance, Community and Address (FICA) framework, which is a structured tool for taking a more detailed spiritual history, as well as phrases clinicians should listen for that may signal unaddressed spiritual distress, such as “Why is this happening to me?” or “I've lost touch with my faith since this diagnosis.”

Subramanian emphasized that neurologists need not act as spiritual counselors but can function as “spiritual generalists” capable of identifying a patient's needs, validating their beliefs and making referrals to chaplains, psychotherapists or community faith leaders when appropriate.

A patient's perspective

The paper includes the voice of Kirk Hall, a patient living with Parkinson's disease and a paper co-author, who describes how faith has been central to navigating his diagnosis.

“It has not escaped me that this is a gift from God, even if I don't necessarily agree with His choice of gift wrap,” Hall writes. “Our belief that we will be equipped to deal with whatever happens is extremely comforting to us.”

His perspective, the authors note, illustrates what research has demonstrated: for many patients, spirituality is not a supplement to medical care, but a foundation for resilience.

Benefits for clinicians

The paper also addresses what the authors describe as an underappreciated dimension of spiritual care in medicine: its potential benefit to clinicians themselves. Studies cited in the paper indicate that spiritual care training is associated with reduced burnout, lower work-related stress and improved well-being among physicians. Practicing medicine in a way that attends to patients' full humanity, the authors argue, may help neurologists find greater meaning in their work.

 

New study identifies key factors supporting indigenous well-being



Large representative study finds 3 in 10 Indigenous adults meet criteria for healthy functioning, highlighting the role of financial security, physical activity, and reduced chronic illness



University of Toronto




The study is among the first to examine strengths-based indicators of well-being in a large, population-level Indigenous sample.

Healthy functioning was significantly associated with never smoking, being physically active, having fewer chronic health conditions, and meeting basic financial needs. These results challenge deficit-focused narratives that blame individuals or groups rather than policies, socioeconomic conditions, and other structural issues. Instead, they underscore the value of identifying factors that support thriving in Indigenous communities.

“Understanding wellness among Indigenous Peoples requires recognizing both the structural barriers created through colonization and the remarkable strengths our communities continue to embody,” said first author Ashley Quinn, an Assistant Professor in the Factor-Inwentash Faculty of Social Work (FIFSW) at the University of Toronto. “Our findings highlight that Indigenous adults can experience meaningful well-being despite longstanding inequities.”

The study, which drew on data from the 2022 and 2023 Behavioral Risk Factor Surveillance System (BRFSS), also found strong connections between socioeconomic stability and healthy functioning. Respondents who could reliably pay their bills or access transportation had substantially higher odds of meeting the study’s well-being criteria.

“Financial security is not simply an economic indicator—it is a health determinant,” said co-author Teagan Miller, a recent Master of Social Work graduate from the FIFSW. “Stable access to food, transportation, and housing meaningfully increases the likelihood of healthy functioning, which reinforces the need for policy interventions that address systemic inequities.”

Chronic physical and mental health conditions were key predictors of lower healthy functioning. Notably, respondents without depression had more than four times the odds of meeting positive well-being criteria compared to those with depression.

“Mental health cannot be separated from community, family, land, and cultural identity,” said  co-author Philip Baiden, an Associate Professor in the School of Social Work at the University of Texas at Arlington. “Interventions that incorporate Indigenous worldviews are essential to supporting emotional wellness and healing.”

Healthy behaviors—including avoiding smoking and engaging in regular physical activity—also played a significant role. More than half of respondents had never smoked, and roughly three-quarters were physically active.

“This study flips the script—shifting the narrative from deficits to the strengths and resilience of Indigenous Peoples,” said co-author Esme Fuller-Thomson, a Professor at FIFSW and Director for the Institute of Life Course and Aging at the University of Toronto.  “Healthy functioning among Indigenous Peoples is not rare—it’s real, measurable, and deeply shaped by social and economic conditions.”

The authors note that while nearly 30% of Indigenous respondents were functioning healthily, two-thirds did not meet the study criteria—indicating a need for expanded public health initiatives that address both structural inequities and culturally meaningful pathways to wellness.

This research contributes to a growing field that emphasizes Indigenous strengths, resilience, and wholistic wellness rather than focusing solely on disparities. The authors call for future studies that incorporate Indigenous-defined measures of health, including community, cultural, spiritual, and environmental dimensions. This research was published recently in the Journal of Indigenous Well-Being.

 

Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic




Canadian Medical Association Journal





New prescriptions for stimulants among adults, largely to treat ADHD, more than doubled since the start of the COVID-19 pandemic, especially in younger adults, found new research published in CMAJ (Canadian Medical Association Journalhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.251065.

In the past, stimulants have been prescribed mainly for pediatric cases of ADHD and some other conditions. However, over the last 20 years, ADHD diagnoses and stimulant prescriptions have increased globally in adults, and data indicate this trend accelerated after the start of the pandemic. Canadian researchers sought to understand whether this trend is evident in Canada and to understand the demographic characteristics of people using these medications.

“Our findings may reflect improved recognition and treatment of ADHD in adulthood; however, the speed and scale of this growth also raises important questions about how diagnoses are being made, and if this prescribing is always appropriate,” says Dr. Tara Gomes, program director of the Ontario Drug Policy Research Network at St. Michael’s Hospital, Unity Health Toronto and an ICES scientist, Toronto, Ontario.

During the study period from January 2016 to June 2024, 327 053 adults in Ontario were dispensed at least 1 new prescription for stimulants. More than half (55%) were female, the median age was 31 years, and the majority (91%) lived in urban areas. The start of the pandemic saw a short-term decline in new recipients of stimulant prescriptions, followed by a subsequent rapid increase. Interestingly, the largest increase and highest rates of new stimulant recipients occurred among younger age groups, most notably among 18- to 24-year-olds. As well, prior to the pandemic, stimulant prescribing rates were similar between males and females, but during the pandemic, rates of stimulant prescriptions were consistently higher among females in all age groups.

“Many of these findings are consistent with trends in stimulant prescribing observed globally in the post-pandemic era and are likely influenced by greater awareness of adult ADHD and improved access to care following a historical pattern of underdiagnosis of ADHD in adulthood — particularly among women,” says coauthor Dr. Mina Tadrous, associate professor, Leslie Dan Faculty of Pharmacy, University of Toronto. “However, the rising impact of social media influencers on ADHD awareness in young adults, as well as the rapid evolution of virtual health services that support online assessments and treatment, may also be contributing to misdiagnoses and potential harm."

Studies in the United States, Australia, the United Kingdom, and Finland have reported similar trends in increasing stimulant use. Increased awareness and diagnosis of adult ADHD, expanded access to prescriptions through virtual care, more time spent on screens, and mental distress are some touted driving factors. The use of prescription stimulants to manage people who have anxiety and depression may also be contributing to the trend, as 25% of new recipients of stimulants were diagnosed with one or both conditions.

The researchers also noted shifts in prescribing patterns, with a decline in prescriptions from psychiatrists after the start of the pandemic (from 26% to 18%) and an increase in prescriptions from nurses and nurse practitioners (from 2% to 10%).

“While greater awareness of adult ADHD has likely supported many people accessing timely care, the speed of rising stimulant prescribing in this population alongside more non-specialist initiation, increasing virtual care, and shorter assessment timelines also raises concerns about the quality of diagnostic practices,” cautions Dr. Gomes. “Because diagnosing adult ADHD requires careful and comprehensive clinical evaluation, these patterns point to the importance of ensuring that rigorous assessment protocols are used to support treatment decisions that are better aligned with clinical standards.”

The authors call for ongoing monitoring and evaluation to understand the root causes of rising rates of stimulant use and balance between treatment when indicated and protecting patients against potential harms.

SCIENCE WODINS DAY